Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer

Sumit K Subudhi; Ana Aparicio; Jianjun Gao; Amado Zurita; Araujo John; Christopher Logothetis; Brinda Rao; Luis Vence; James Allison; Ryan O Emerson; Erik Yusko; Marissa Vignali; Harlan Robins; Jing Jing Sun; Padmanee Sharma

doi:10.1186/2051-1426-3-S2-P106

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

Poster Presentation

Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Subudhi SK, Aparicio A, Gao J, et al

Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer

Journal for ImmunoTherapy of Cancer 2015;3:P106. doi: 10.1186/2051-1426-3-S2-P106

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password